Cosmos Holdings Inc. Common Stock (COSM) — Analysis Summary
Cosmos Holdings Inc. Common Stock (COSM) has a market cap of $35.18M with year-over-year revenue growth of +19.9%. Net margin stands at -29.3%. The stock trades at a P/E ratio of -1.4.
Key Takeaways
- Revenue changed +19.9% year-over-year
- Net margin of -29.3%
- P/E ratio of -1.4
Compared to other companies in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector, COSM posted revenue growth of +19.9% and trades at a P/E of -1.4.
Cosmos Holdings Inc. Common Stock (COSM)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -7.8x — earnings do not cover interest payments
Operating margin at -24.9% — material operating losses
Net margin at -33.1% — significant losses
The latest filing shows negative free cash flow.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Sector
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Employees
163
Headquarters
THESSALONIKI, J3
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.